361 Capital’s Oracle ORCL Stock Holding History

361 Capital’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-54,866	Closed	-$2.75M	–	285
2017 Q2	$2.75M	Buy	54,866 +26,843	+96%	+$1.22M	0.46%	74
2017 Q1	$1.25M	Buy	+28,023	New	+$1.17M	0.27%	82

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

361 Capital's ORCL Position: Q3 2017 in Review

361 Capital sold out of Oracle (ORCL) in Q3 2017, closing a stake of 54,866 shares — an estimated $2.75M sold.

361 Capital first reported a position in ORCL in Q1 2017 and held it in 2 quarters. The position peaked at $2.75M in Q2 2017. 1,641 funds tracked by Wall St. Rank hold ORCL as of Q3 2017.

361 Capital reported no remaining Oracle position as of Q3 2017 after selling out during the quarter.
361 Capital sold 54,866 Oracle shares in Q3 2017, an estimated $2.75M.
361 Capital first reported a position in Oracle in Q1 2017 and held it in 2 quarters.
361 Capital's Oracle position peaked at $2.75M in Q2 2017.
1,641 funds tracked by Wall St. Rank held Oracle as of Q3 2017.

Based on 361 Capital's 13F filing for Q3 2017, filed 7 Nov 2017.